PLX
Protalix Biotherapeutics Inc
2.80$
+3.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 18.7 | 13.4 | 15.8 | 13.9 | – | – | 52.5 | 51.0 | 19.4 | 33.0 | – | 11.9 | 10.0 | |
| – | 6.1 | 15.3 | 10.1 | 4.1 | 5.0 | 3.8 | 3.3 | 4.5 | 0.9 | 1.2 | 1.1 | 0.5 | 0.9 | 0.6 | 1.9 | 2.1 | 1.9 | 3.4 | 1.8 | 1.2 | 1.0 | 1.2 | 1.1 | 1.0 | 1.5 | 2.9 | 2.5 | 2.2 | 2.0 | 1.6 | 2.3 | 1.8 | 2.9 | 3.3 | 2.0 | 2.9 | 2.7 | 2.4 | 2.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 12.4 | 22.5 | 278.0 | – | – | – | – | – | 119.8 | 4.3 | 3.7 | 3.9 | 3.2 | 3.1 | 2.5 | 3.6 | 4.4 | 2.4 | 3.4 | 2.9 | 2.7 | 2.7 | |
| – | 7.6 | 26.1 | 15.2 | 5.7 | 5.3 | 4.5 | 6.1 | 7.2 | 1.2 | 1.6 | 1.5 | 1.0 | 1.6 | 1.3 | 2.7 | 2.8 | 2.5 | 4.1 | 2.3 | 1.6 | 0.7 | 1.5 | 1.5 | 1.4 | 1.8 | 2.8 | 2.1 | 2.3 | 2.0 | 1.5 | 2.3 | 1.2 | 2.5 | 3.0 | 1.7 | 2.7 | 2.4 | 1.9 | 2.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 107.0 | – | 55.8 | 34.6 | 43.0 | 36.0 | – | – | – | – | – | – | – | – | – | 9.8 | 9.0 | 10.0 | 8.2 | – | – | 20.8 | 25.3 | 10.0 | 18.7 | – | 6.4 | 6.2 | |
| – | – | – | – | – | – | – | – | 8.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 21.7 | – | 11.3 | 20.8 | – | – | – | – | 14.1 | 24.8 | |
| -51.6% | -58.8% | -18.2% | -17.7% | -46.5% | -11.4% | -15.3% | -17.7% | 12.1% | -18.3% | -9.5% | -4.7% | -65.7% | -40.8% | -47.3% | -18.3% | -17.7% | -22.6% | -16.6% | -18.0% | -23.7% | -31.1% | -15.0% | -40.9% | -57.3% | -35.7% | -18.9% | -6.3% | -6.1% | -1.9% | 4.6% | -4.8% | 8.8% | 4.8% | -0.8% | -2.8% | -6.6% | -9.6% | 7.1% | 4.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | 8.7% | 12.7% | 13.7% | 17.1% | 20.8% | 23.1% | 19.7% | 52.8% | 75.1% | 79.4% | 85.6% | 84.0% | 80.1% | 81.4% | 82.3% | 81.9% | 82.7% | 76.8% | 68.5% | 67.6% | 57.4% | 59.1% | 62.7% | 57.2% | 58.9% | 59.5% | 72.3% | 74.0% | 64.9% | 62.3% | 32.2% | 35.9% | 54.5% | 50.0% | 57.5% | 57.5% | 48.8% | 70.0% | 69.2% | |
| – | -360.5% | -277.5% | -203.4% | -178.5% | -188.9% | -168.1% | -160.3% | -111.8% | -39.6% | -36.0% | -30.3% | -25.9% | -19.6% | -0.7% | 4.8% | 3.4% | 4.3% | -10.8% | -26.3% | -24.2% | -53.4% | -43.2% | -33.0% | -34.1% | -27.3% | -33.1% | 18.3% | 21.3% | 16.0% | 13.5% | -38.9% | -19.5% | 7.3% | 7.7% | 13.3% | 10.3% | -10.4% | 25.9% | 28.9% | |
| – | -319.2% | -700.5% | -428.9% | -385.9% | -443.2% | -159.6% | -218.1% | -149.5% | -23.1% | -20.6% | -17.0% | -13.7% | -33.4% | -14.2% | -8.9% | -10.8% | -10.4% | -26.0% | -43.2% | -41.6% | -71.9% | -56.6% | -40.7% | -37.5% | -31.3% | -38.3% | 13.2% | 16.7% | 12.7% | 11.5% | -38.6% | -21.0% | 5.5% | 6.5% | 10.1% | 8.7% | -12.5% | 20.1% | 23.5% | |
| – | -358.2% | -278.0% | -179.0% | -189.5% | -57.0% | -57.3% | -57.5% | 54.0% | -17.3% | -11.4% | -5.3% | -32.0% | -36.5% | -29.9% | -34.9% | -37.0% | -42.5% | -56.7% | -32.3% | -28.5% | -30.6% | -17.6% | -46.9% | -59.6% | -53.8% | -55.5% | -15.7% | -13.6% | -3.8% | 7.3% | -11.0% | 15.7% | 13.8% | -2.6% | -5.6% | -18.9% | -25.8% | 17.0% | 9.5% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -94.2% | -540.4% | -9,632.9% | – | – | – | – | – | -1,564.7% | 22.8% | 27.8% | 24.8% | 23.0% | -51.4% | -29.6% | 6.8% | 8.6% | 12.6% | 10.2% | -13.7% | 22.8% | 26.5% | |
| -56.3% | -35.7% | -111.2% | -116.3% | -119.2% | -118.1% | -51.5% | -81.7% | -53.8% | -18.4% | -18.5% | -19.1% | -16.4% | -40.3% | -11.3% | -8.0% | -9.2% | -9.6% | -13.3% | -19.2% | -24.6% | -37.4% | -35.7% | -30.5% | -31.5% | -26.8% | -23.7% | 10.1% | 12.1% | 9.8% | 7.6% | -16.1% | -15.6% | 4.0% | 5.3% | 8.0% | 6.6% | -8.0% | 15.0% | 17.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 94 | 14 | 123 | 81 | 30 | 5.3 | 16 | 56 | 67 | 14 | 20 | 26 | 30 | 39 | 43 | 53 | 45 | 42 | 37 | 24 | 22 | -9.9 | 12 | 17 | 18 | 12 | -3.6 | -27 | 1.1 | -2.0 | -5.3 | -0.1 | -26 | -18 | -18 | -16 | -12 | -13 | -40 | -26 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 52.4 | – | 28.4 | 10.4 | 11.3 | 9.4 | – | – | – | – | – | – | – | – | – | -1.9 | 0.1 | -0.2 | -0.5 | – | – | -2.8 | -2.5 | -1.6 | -1.4 | – | -1.8 | -1.0 | |
| -21.4% | -12.1% | -95.3% | -35.0% | -42.7% | -43.3% | -60.9% | -95.8% | -96.7% | -86.5% | -98.1% | -122.2% | -131.9% | -154.9% | -37.3% | -48.5% | -46.1% | -39.8% | 14.1% | 3.5% | 0.3% | -8.2% | -10.9% | -16.3% | -20.3% | -19.1% | 1.5% | 44.1% | 43.7% | 39.8% | 33.2% | 31.2% | 52.7% | 58.9% | 61.2% | 63.6% | 64.3% | 58.6% | 65.7% | 64.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.9 | 15.0 | 151.6 | – | – | – | – | – | 29.2 | 0.5 | 0.6 | 0.6 | 0.7 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -3.97 | -2.36 | -6.42 | -3.56 | -5.49 | -5.87 | -2.30 | -2.88 | -2.44 | -0.76 | -0.76 | -0.71 | -0.59 | -1.23 | -0.54 | -0.18 | -0.20 | -0.20 | -0.34 | -0.46 | -0.45 | -0.61 | -0.53 | -0.39 | -0.36 | -0.29 | -0.27 | 0.11 | 0.13 | 0.11 | 0.09 | -0.20 | -0.12 | 0.04 | 0.05 | 0.08 | 0.07 | -0.08 | 0.18 | 0.23 | |
| -0.41 | 0.74 | 0.92 | 0.83 | 1.42 | 1.32 | 1.44 | 1.32 | 1.63 | 3.29 | 3.68 | 4.18 | 4.31 | 3.69 | 3.79 | 1.99 | 1.86 | 1.91 | 1.32 | 1.06 | 1.08 | 0.84 | 0.94 | 0.96 | 0.96 | 0.93 | 0.72 | 0.81 | 0.76 | 0.90 | 0.82 | 0.52 | 0.56 | 0.66 | 0.78 | 0.76 | 0.77 | 0.67 | 0.92 | 0.98 | |
| -1.51 | -0.80 | -5.50 | -1.07 | -1.97 | -2.15 | -2.71 | -3.38 | -4.39 | -3.56 | -4.03 | -4.55 | -4.77 | -4.74 | -1.78 | -1.07 | -1.01 | -0.82 | 0.36 | 0.08 | 0.00 | -0.13 | -0.16 | -0.21 | -0.23 | -0.21 | 0.02 | 0.47 | 0.46 | 0.46 | 0.41 | 0.39 | 0.40 | 0.53 | 0.59 | 0.61 | 0.65 | 0.61 | 0.81 | 0.86 | |
| -2.94 | -2.65 | -2.55 | -1.49 | -2.69 | -0.75 | -0.82 | -0.76 | 0.88 | -0.57 | -0.42 | -0.22 | -1.38 | -1.35 | -1.13 | -0.70 | -0.69 | -0.81 | -0.75 | -0.34 | -0.31 | -0.26 | -0.17 | -0.45 | -0.57 | -0.50 | -0.40 | -0.13 | -0.10 | -0.03 | 0.06 | -0.06 | 0.09 | 0.09 | -0.02 | -0.04 | -0.14 | -0.17 | 0.16 | 0.09 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.